Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES2 | Q9H7Z7 | 9/20 | 0.76 |
| ▸ | LMNA | P02545 | 3/20 | 0.76 |
| ▸ | HTT | P42858 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.51 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Artemotil SCHEMBL1648554 | 1.00 | PTGES2 (0.76) | PTGES2LMNAHTTALDH1A1CYP3A4 | |
| Artemotil SCHEMBL16710281 | 1.00 | PTGES2 (0.76) | PTGES2LMNAHTTALDH1A1CYP3A4 | |
| Artemotil SCHEMBL17156474 | 1.00 | PTGES2 (0.76) | PTGES2LMNAHTTALDH1A1CYP3A4 | |
| Artemotil SCHEMBL16404848 | 1.00 | PTGES2 (0.76) | PTGES2LMNAHTTALDH1A1CYP3A4 | |
| Artemotil SCHEMBL341227 | 1.00 | PTGES2 (0.76) | PTGES2LMNAHTTALDH1A1CYP3A4 | |
| Artemotil SCHEMBL18422062 | 1.00 | PTGES2 (0.76) | PTGES2LMNAHTTALDH1A1CYP3A4 | |
| Artemotil SCHEMBL10041607 | 1.00 | PTGES2 (0.76) | PTGES2LMNAHTTALDH1A1CYP3A4 | |
| Artemotil SCHEMBL60336 | 1.00 | PTGES2 (0.76) | PTGES2LMNAHTTALDH1A1CYP3A4 | |
| Artemotil SCHEMBL4539927 | 1.00 | PTGES2 (0.76) | PTGES2LMNAHTTALDH1A1CYP3A4 | |
| Artemotil SCHEMBL18950949 | 1.00 | PTGES2 (0.76) | PTGES2LMNAHTTALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3232 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250375399-A1 | LIQUID INJECTABLE COMPOSITION | AMATERASU LIFESCIENCES LLP (IN) | 2025-12-11 | — | — | US | claimed |
| US-12485116-B2 | Pharmaceutical composition for preventing or treating epidemic RNA viral infectious disease | SHIN POONG PHARMACEUTICAL CO., LTD. (KR) | 2025-12-02 | — | — | US | claimed |
| EP-3625238-B1 | NOVEL SPIRO-LACTAM COMPOUNDS, PROCESS AND USES THEREOF | UNIV DE COIMBRA (PT) | 2025-11-26 | — | — | EP | claimed |
| US-12448559-B1 | Puddle job with delayed setting of resin via a polymerization reaction with an activator | HALLIBURTON ENERGY SERVICES, INC. (US) | 2025-10-21 | — | — | US | claimed |
| US-12433869-B2 | Preventing and treating malaria | Shine, Ian Basil (US) | 2025-10-07 | — | — | US | claimed |
| US-12409153-B2 | Liquid injectable composition | AMATERASU LIFESCIENCES LLP (IN) | 2025-09-09 | — | — | US | claimed |
| EP-4129290-B1 | PHARMACEUTICAL COMPOSITION COMPRISING PYRONARIDINE OR A SALT THEREOF, ARTEMISININ OR A DERIVATIVE THEREOF OR A COMBINATION OF BOTH FOR PREVENTING OR TREATING A RESPIRATORY DISEASE CAUSED BY A CORONAVIRUS | SHIN POONG PHARMACEUTICAL CO LTD (KR) | 2025-07-09 | — | — | EP | claimed |
| WO-2025133260-A1 | INHIBITORS OF PLASMODIA REMODELING ENZYMES | UNIVERSITÄT REGENSBURG, IN VERTRETUNG DES FREISTAATES BAYERN (DE) | 2025-06-26 | — | — | WO | claimed |
| EP-4574143-A1 | INHIBITORS OF PLASMODIA REMODELING ENZYMES | Universität Regensburg (DE) | 2025-06-25 | — | — | EP | claimed |
| EP-3990434-B1 | 1,1'-[1,3-(5-METHOXY)PHENYLENEBIS(METHYLENE)]BIS[4,5-DIPHENYL-1H-IMIDAZOLE] AND SIMILAR COMPOUNDS FOR THE TREATMENT OF MALARIA | UNIV NANYANG TECH (SG) | 2025-06-25 | — | — | EP | claimed |
| CN-1065993-A | The preparation method of synergistic antimalarial compound benzfluorenol | MICROBIOLOGICAL EPIDEMIOLOGY I (CN) | 1992-11-11 | — | — | CN | claimed |
| EP-0500823-A1 | ANTIMALARIAL COMPOSITIONS. | CIBA GEIGY AG (CH) | 1992-09-02 | — | — | EP | claimed |
| WO-1992002217-A1 | ANTIMALARIAL COMPOSITIONS | CIBA-GEIGY AG (CH) | 1992-02-20 | — | — | WO | claimed |
| EP-0464233-A1 | Pharmaceutical combinations against malaria | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-01-08 | — | — | EP | claimed |
| US-5057501-A | Methods for treatment of papulosquamous and eczematous diseases | DERMATOLOGIC RESEARCH CORPORATION (US) | 1991-10-15 | — | — | US | claimed |
| US-5011951-A | Synthesis of artemisininelactol derivatives | WORLD HEALTH ORGANIZATION (CH) | 1991-04-30 | — | — | US | claimed |
| CN-1041694-A | The anti-malaria composition of quinidine, arteannuin and derivant thereof and Therapeutic Method | HOECHST AG (DE) | 1990-05-02 | — | — | CN | claimed |
| EP-0362810-A1 | Antimalarial compositions using quinidine, artemisinine and its derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-04-11 | — | — | EP | claimed |
| EP-0330520-A1 | Synthesis of artemisininelactol derivatives | WORLD HEALTH ORGANISATION (CH) | 1989-08-30 | — | — | EP | claimed |
| EP-0290959-A2 | Drug mixture for prophylaxis and therapy of malaria | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-11-17 | — | — | EP | claimed |